[go: up one dir, main page]

MXPA04011664A - Probioticos y tolerancia oral. - Google Patents

Probioticos y tolerancia oral.

Info

Publication number
MXPA04011664A
MXPA04011664A MXPA04011664A MXPA04011664A MXPA04011664A MX PA04011664 A MXPA04011664 A MX PA04011664A MX PA04011664 A MXPA04011664 A MX PA04011664A MX PA04011664 A MXPA04011664 A MX PA04011664A MX PA04011664 A MXPA04011664 A MX PA04011664A
Authority
MX
Mexico
Prior art keywords
oral tolerance
food products
probiotics
promote
tolerance phenomenon
Prior art date
Application number
MXPA04011664A
Other languages
English (en)
Inventor
Prioult Guenolee
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MXPA04011664A publication Critical patent/MXPA04011664A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

La invencion se refiere a productos alimenticios que comprenden por lo menos un medo par promover el fenomeno de la tolerancia oral (Lactobacillus paracasei), a productos alimenticios que incluye por lo menos un medio para mantener el fenomeno de tolerancia oral (Bifidobacterium lactis), y a productos alimenticios que incluyen medios para promover y mantener el fenomeno de tolerancia oral (combinacion de Lactobacillus y Bifidobacteria). El producto alimenticio esta destinado para infantes, bebes, ninos y tambien para cascotas. La invencion se refiere a productos alimenticios los cuales no estan indicados para personas alergicas.
MXPA04011664A 2002-05-24 2003-05-22 Probioticos y tolerancia oral. MXPA04011664A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02011444A EP1364586A1 (en) 2002-05-24 2002-05-24 Probiotics and oral tolerance
PCT/EP2003/005354 WO2003099037A1 (en) 2002-05-24 2003-05-22 Probiotics and oral tolerance

Publications (1)

Publication Number Publication Date
MXPA04011664A true MXPA04011664A (es) 2005-03-07

Family

ID=29286151

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04011664A MXPA04011664A (es) 2002-05-24 2003-05-22 Probioticos y tolerancia oral.

Country Status (14)

Country Link
US (1) US20050180961A1 (es)
EP (2) EP1364586A1 (es)
JP (1) JP2005538703A (es)
KR (1) KR20050004223A (es)
CN (1) CN1662154A (es)
AU (1) AU2003242557A1 (es)
BR (1) BR0311281A (es)
CA (1) CA2487021A1 (es)
IL (1) IL165333A0 (es)
MX (1) MXPA04011664A (es)
NO (1) NO20045588L (es)
RU (1) RU2004137806A (es)
WO (1) WO2003099037A1 (es)
ZA (1) ZA200410399B (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110555A1 (fr) 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
MXPA04008187A (es) * 2002-02-21 2004-11-26 Nestle Sa Composicion de alimento para mascotas, para la fotoproteccion de la piel.
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
TWI324068B (en) * 2003-03-13 2010-05-01 Kirin Holdings Kk Antiallergic composition
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
WO2006000992A1 (en) * 2004-06-23 2006-01-05 L'oreal Method and compositions useful for preventing and/or treating sensitive and/or dry skin
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
MX2007004135A (es) * 2004-10-04 2007-06-15 Oreal Composicion cosmetica y/o dermatologica para pieles sensibles.
EP1642570A1 (fr) 2004-10-04 2006-04-05 L'oreal Composition cosmétique et/ou dermatologique pour peaux sensibles
EP1731137A1 (fr) * 2005-06-08 2006-12-13 Nestec S.A. Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles
RU2270248C1 (ru) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
RU2290437C2 (ru) * 2005-02-22 2006-12-27 Открытое акционерное общество "Вимм-Билль-Данн" Штамм bifidobacterium lactis 678, используемый для приготовления кисломолочных лечебно-профилактических продуктов, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, пробиотика и косметических средств
RU2290436C2 (ru) * 2005-02-22 2006-12-27 Открытое акционерное общество "Вимм-Билль-Данн" Штамм bifidobacterium lactis 676, используемый для приготовления кисломолочных лечебно-профилактических продуктов, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, пробиотика и косметических средств
RU2296156C2 (ru) * 2005-02-22 2007-03-27 Открытое акционерное общество "Вимм-Билль -Данн" Штамм bifidobacterium lactis 672, используемый для приготовления кисломолочных лечебно-профилактических продуктов, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, пробиотика и косметических средств
WO2006091103A2 (en) * 2005-02-28 2006-08-31 N.V. Nutricia Nutritional composition with probiotics
EP1926395A1 (en) * 2005-04-13 2008-06-04 Nestec S.A. Infant formula with probiotics
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
ATE423196T1 (de) * 2005-05-11 2009-03-15 Hansens Lab Antibiotikasensitive milchsäurebakterienstämme
EP2264164A1 (en) 2005-05-11 2010-12-22 Chr. Hansen A/S New antibiotic-sensitive lactic acid bacteria strains
EP1885383B1 (en) * 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
WO2006130187A1 (en) * 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
RU2411038C2 (ru) * 2005-10-06 2011-02-10 Нестек С.А. Способ усиления эффективности вакцины и применение пробиотического штамма enterococcus faecium sf68 для усиления эффективности вакцины
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
JP2009515929A (ja) 2005-11-14 2009-04-16 ネステク ソシエテ アノニム 糖化タンパク質を用いた経口免疫寛容促進
RU2420569C2 (ru) 2005-11-29 2011-06-10 Актогеникс Нв Индукция толерантности к антигенам через слизистую
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
WO2008058854A1 (en) 2006-11-15 2008-05-22 Chr. Hansen A/S New tetracycline-sensitive bifidobacteria strains
WO2008090223A2 (en) 2007-01-25 2008-07-31 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
RU2468808C2 (ru) * 2007-02-28 2012-12-10 Мид Джонсон Нутришен Компани Способ лечения или предотвращения системного воспаления
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
CN101815502B (zh) * 2007-09-04 2013-10-09 欧莱雅 橙皮苷和微生物的组合在影响皮肤的屏障功能中的用途
SI2244734T1 (sl) 2008-02-01 2016-11-30 Murdoch Childrens Research Institute Postopek induciranja tolerance na alergen
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2009151315A1 (en) * 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
AR072142A1 (es) 2008-06-13 2010-08-11 Nutricia Nv Nutricion para prevenir infecciones.proceso. composicion. uso.
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
CN101768559B (zh) * 2008-12-31 2012-03-07 生展生物科技股份有限公司 副干酪乳杆菌副干酪亚种菌株及其抑菌组合物和用途
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
MX338680B (es) * 2009-05-11 2016-04-27 Nestec Sa Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2332557A1 (en) 2009-12-08 2011-06-15 Campina Nederland Holding B.V. Probiotic lactic acid bacteria
ES2600312T3 (es) * 2010-08-03 2017-02-08 Hill's Pet Nutrition, Inc. Composiciones de alimento para mascotas que tienen actividad antimicrobiana
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
ES3005933T3 (en) * 2011-06-20 2025-03-17 Heinz Co Brands H J Llc Probiotic compositions and methods
US20140170126A1 (en) * 2011-07-12 2014-06-19 Nestec S.A. Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
ES3010649T3 (en) 2012-06-18 2025-04-04 Heinz Co Brands H J Llc Gluten-related disorders
MX370692B (es) 2013-05-10 2019-12-19 Heinz Co Brands H J Llc Probióticos y métodos de uso.
EP3079502A1 (en) 2013-11-04 2016-10-19 N.V. Nutricia Fermented formula with non digestible oligosaccharides
JP6590330B2 (ja) * 2013-11-11 2019-10-16 キッコーマン株式会社 経口免疫寛容増強物質のスクリーニング方法および経口免疫寛容増強組成物
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2016148562A1 (en) * 2015-03-18 2016-09-22 N.V. Nutricia Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic
WO2017109735A1 (en) * 2015-12-22 2017-06-29 Nestec Sa Oral health for companion animals
US20180185421A1 (en) * 2016-08-29 2018-07-05 Tokyo Metropolitan Government Composition comprising fecal microbiota
JP2020000033A (ja) * 2018-06-26 2020-01-09 国立大学法人広島大学 経口免疫寛容誘導剤、これを含有する食品および医薬品、ならびに加工食品の製造方法
CN119790135A (zh) 2022-08-25 2025-04-08 科·汉森有限公司 具有改善的稳定性的双歧杆菌菌株
CN120441663A (zh) * 2024-02-07 2025-08-08 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99菌泌素、制备方法及其抗氧化应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
JPH10309178A (ja) * 1997-05-09 1998-11-24 Wakamoto Pharmaceut Co Ltd ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
EP1251747B1 (en) * 2000-01-18 2012-01-25 Société des Produits Nestlé S.A. Pet food composition for treating helicobacter species in pets
JP2001231495A (ja) * 2000-02-18 2001-08-28 Nichinichi Seiyaku Kk 好酸球集積抑制作用を有する食品
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance

Also Published As

Publication number Publication date
US20050180961A1 (en) 2005-08-18
EP1364586A1 (en) 2003-11-26
NO20045588L (no) 2005-02-23
CN1662154A (zh) 2005-08-31
WO2003099037A1 (en) 2003-12-04
JP2005538703A (ja) 2005-12-22
EP1511394A1 (en) 2005-03-09
RU2004137806A (ru) 2005-08-20
AU2003242557A1 (en) 2003-12-12
BR0311281A (pt) 2005-03-29
KR20050004223A (ko) 2005-01-12
CA2487021A1 (en) 2003-12-04
ZA200410399B (en) 2006-02-22
IL165333A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
MXPA04011664A (es) Probioticos y tolerancia oral.
DK1359816T3 (da) Kombination af probiotika
WO2010103140A3 (es) Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
PL2114423T3 (pl) Produkt zawierający unieczynniony probiotyk dla niemowląt
MY203053A (en) Nutritional composition, food/drink composition using nutritional composition, and modified milk powder using nutritional composition
MY150459A (en) Infant formula with probiotics
PH12014501749B1 (en) A nutritional composition comprising probiotics and improving sleep patterns
DE602004006133D1 (de) Neue galactooligosaccharidzusammensetzung und herstellung davon
EP1634600A4 (en) ANTIALLERGIC COMPOSITION
HUP0100428A2 (hu) Lactobacillus paracasei subsp. paracasei fajhoz tartozó baktériumtörzs, abból élelmiszeripari alkalmazás céljára előállított készítmények, valamint a baktériumtörzset tartalmazó termékek
IL194318A (en) Beta-galactosidase that has trans-galactosylation activity and its use
EP0861905A3 (en) Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system
IL161995A (en) Purified strain of lactic acid bacterium and uses thereof in the preparation of edible compositions, drugs and veterinary products
ZA200806175B (en) Galactosidalse with alpha-galactosyltransferase activity
FI20075539A0 (fi) Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
AU8280001A (en) New strains of lactobacillus paracasei
EE200300220A (et) Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod
Saarela et al. Gut feeling.
GEU20061256Y (en) Yoghurt
RU2000110304A (ru) Штамм bifidobacterium bifidum 791, используемый для приготовления кисломолочных, неферментированных продуктов, биологически активных добавок, косметических и гигиенических средств

Legal Events

Date Code Title Description
FA Abandonment or withdrawal